Patent · US Active

Chimeric antigen receptors and uses thereof

US12383601B2 · kind B2 · utility

0Cited by

43References

21Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Aida Abujoub · Winchester, US
John W. Blankenship · Acton, US
Attilio Bondanza · Basel, CH
Jennifer Brogdon · Cambridge, US
Dexiu Bu · Melrose, US
Serena De Vita · Boston, US
Glenn Dranoff · Lexington, US
Boris Engels · Arlington, US
Tony Fleming · Stow, US
Brian Granda · Cambridge, US
Michael R. Greene · Long Valley, US
Carla Guimaraes · Boston, US
Anniesha Hack · Hanover Center, US
Brian Holmberg · Somerville, US
Connie Hong · Somerville, US
Lu Huang · Riverdale, US
Olja Kodrasi · Quincy, US
Joni Waiee Lam · Somerville, US
Hyungwook Lim · Newton, US
Elizabeth D. Pratico · Durham, US
Andrew Price · Cambridge, US
Akash Sohoni · Cambridge, US
Andrew M. Stein · Cambridge, US
Louise Treanor · Cambridge, US
Chonghui Zhang · Brookline, US
Xu Zhu · Cambridge, US

Key dates

Filing date	Nov 25, 2020
Grant date	Aug 12, 2025
Priority date	—
Expiry date	Feb 22, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/2321
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides immune effector cells (for example, T cells, NK cells) that express a chimeric antigen receptor (CAR), and compositions and methods thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.